Biostasis Technologies, Inc. is a human cryopreservation R&D organization with the following objectives:
(A) Experimental and theoretical research aimed at improving hypothermic tissue stabilization of legally deceased individuals and/or terminally ill patients, as permitted by law, for organ preservation, brain banking, anatomical donation, and human biostasis.
(B) Publication and dissemination of research reports, protocols, and clinical standards to improve the practice and delivery of hypothermic tissue stabilization.
(C) Education, training, and certification of medical professionals to conduct hypothermic tissue stabilization delivery services.
(D) Assisting in the formation of regional hypothermic tissue stabilization delivery organizations and monitoring protocol compliance.
Company Details
- Employees
- 5
- Founded
- -
- Address
- New York City, New York 11222, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Scottsdale.
- HQ
- New York City, New York
Biostasis Technologies Questions
Biostasis Technologies's website is https://www.biostasistechnologies.org/
Biostasis Technologies's LinkedIn profile is https://www.linkedin.com/company/biostasis-technologies
Biostasis Technologies has
5 employees.
View email and phone details for 5
employees at Biostasis Technologies.
Biostasis Technologies's industry is
Biotechnology Research
Biostasis Technologies's top competitors are
The Art Of Medicine,
European Biostasis Foundation,
Tomorrow Biostasis Gmbh,
Alcor,
Testing & Holistic Extractions Laboratories,
Cannacares Llc,
Kriorus,
Alcor Life Extension Foundation,
Pure Chemistry Consulting,
Genspace Nyc.
Biostasis Technologies's categories are Biotechnology Research
Biostasis Technologies's founding year is 2022
